Protocol Ledger

NCT04214990 · Phase III · RECRUITING

Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

Interventional Phase III clinical trial protocol NCT04214990 sponsored by National Cancer Center, Korea in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-02-15 Enrollment: 1,700 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04214990
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,700 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04214990
Protocol FieldVerified Registry Value
NCT IdentifierNCT04214990
Consolidated Lead SponsorNational Cancer Center, Korea
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,700 participants (ESTIMATED)
Registered Start Date2020-02-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04214990
Hospital Research SiteLocationSite Profile
Pusan National University HospitalBusan, South KoreaOpen Hospital Dossier ->
Kyungpook National University Chilgok HospitalDaegu, South KoreaOpen Hospital Dossier ->
Chonnam National University HospitalGwangju, South KoreaOpen Hospital Dossier ->
Chung-Ang University HospitalSeoul, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI